Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus (TARGET-DLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02656082
Recruitment Status : Completed
First Posted : January 14, 2016
Last Update Posted : February 27, 2019
Sponsor:
Collaborators:
National Institute for Health Research, United Kingdom
Pfizer
Clinical Trials Research Unit, Leeds
Information provided by (Responsible Party):
Yuzaiful Md Yusof, University of Leeds

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 31, 2017
  Actual Study Completion Date : December 31, 2017